Torthaí cuardaigh - John F. Kokai–Kun
- 1 - 16 toradh as 16 á dtaispeáint
-
1
Comparison of Four Methods for Determining Lysostaphin Susceptibility of Various Strains of <i>Staphylococcus aureus</i> de réir Caroline M. Kusuma, John F. Kokai–Kun
Foilsithe / Cruthaithe 2005Artigo -
2
Deletion analysis of the Clostridium perfringens enterotoxin de réir John F. Kokai–Kun, Bruce A. McClane
Foilsithe / Cruthaithe 1997Artigo -
3
Lysostaphin as a treatment for systemic Staphylococcus aureus infection in a mouse model de réir John F. Kokai–Kun, Tanya Chanturiya, J J Mond
Foilsithe / Cruthaithe 2007Artigo -
4
Lysostaphin eradicates established Staphylococcus aureus biofilms in jugular vein catheterized mice de réir John F. Kokai–Kun, Tanya Chanturiya, James J. Mond
Foilsithe / Cruthaithe 2009Artigo -
5
Lysostaphin Cream Eradicates <i>Staphylococcus aureus</i> Nasal Colonization in a Cotton Rat Model de réir John F. Kokai–Kun, S. M. Walsh, Tanya Chanturiya, James J. Mond
Foilsithe / Cruthaithe 2003Artigo -
6
Lysostaphin Disrupts <i>Staphylococcus aureus</i> and <i>Staphylococcus epidermidis</i> Biofilms on Artificial Surfaces de réir Julie A. Wu, Caroline M. Kusuma, James J. Mond, John F. Kokai–Kun
Foilsithe / Cruthaithe 2003Artigo -
7
COVID-19 vaccine platforms: Delivering on a promise? de réir Mark Verdecia, John F. Kokai–Kun, Maura Kibbey, Sarita Acharya, Jaap Venema, Fouad Atouf
Foilsithe / Cruthaithe 2021Revisão -
8
Comparison of Western immunoblots and gene detection assays for identification of potentially enterotoxigenic isolates of Clostridium perfringens de réir John F. Kokai–Kun, J. Glenn Songer, John R. Czeczulin, Fei Chen, Bruce A. McClane
Foilsithe / Cruthaithe 1994Artigo -
9
Catalase (KatA) and Alkyl Hydroperoxide Reductase (AhpC) Have Compensatory Roles in Peroxide Stress Resistance and Are Required for Survival, Persistence, and Nasal Colonization in... de réir Kate Cosgrove, Graham Coutts, Ing‐Marie Jonsson, Andrej Tarkowski, John F. Kokai–Kun, James J. Mond, Simon J. Foster
Foilsithe / Cruthaithe 2006Artigo -
10
Use of ribaxamase (SYN-004), a β-lactamase, to prevent Clostridium difficile infection in β-lactam-treated patients: a double-blind, phase 2b, randomised placebo-controlled trial de réir John F. Kokai–Kun, Tracey Roberts, Olivia Coughlin, Chenxiong Le, Heidi Whalen, Ralph W. Stevenson, Vincent J. Wacher, Joseph Sliman
Foilsithe / Cruthaithe 2019Artigo -
11
The Staphylococcus aureus Surface Protein IsdA Mediates Resistance to Innate Defenses of Human Skin de réir Simon R. Clarke, Ramlan Mohamed, Bian Li, Alexander F. Routh, John F. Kokai–Kun, James J. Mond, Andrej Tarkowski, Simon J. Foster
Foilsithe / Cruthaithe 2007Artigo -
12
Characterization of IsaA and SceD, Two Putative Lytic Transglycosylases of <i>Staphylococcus aureus</i> de réir Melanie R. Stapleton, Malcolm J. Horsburgh, Emma J. Hayhurst, Lynda Wright, Ing‐Marie Jonsson, Andrej Tarkowski, John F. Kokai–Kun, James J. Mond, Simon J. Foster
Foilsithe / Cruthaithe 2007Artigo -
13
The Oral β-Lactamase SYN-004 (Ribaxamase) Degrades Ceftriaxone Excreted into the Intestine in Phase 2a Clinical Studies de réir John F. Kokai–Kun, Tracey Roberts, Olivia Coughlin, Éric Sicard, Marianne Rufiange, Richard N. Fedorak, Christian Carter, Marijke H. Adams, James Longstreth, Heidi Whalen, Joseph Sliman
Foilsithe / Cruthaithe 2017Artigo -
14
Phase 1/2 Double-Blind, Placebo-Controlled, Dose Escalation, Safety, and Pharmacokinetic Study of Pagibaximab (BSYX-A110), an Antistaphylococcal Monoclonal Antibody for the Prevent... de réir Leonard E. Weisman, Helen Thackray, Joseph A. Garcia‐Prats, Mirjana Nesin, Joseph H. Schneider, Jennifer Fretz, John F. Kokai–Kun, James J. Mond, William G. Kramer, G. Fischer
Foilsithe / Cruthaithe 2009Artigo -
15
Development of SYN-004, an oral beta-lactamase treatment to protect the gut microbiome from antibiotic-mediated damage and prevent Clostridium difficile infection de réir Michael Kaleko, J. Andrew Bristol, Steven Hubert, Todd B. Parsley, Giovanni Widmer, Saul Tzipori, Poorani Subramanian, Nur A. Hasan, Perrti Koski, John F. Kokai–Kun, Joseph Sliman, Annie Jones, Sheila Connelly
Foilsithe / Cruthaithe 2016Artigo -
16
Identification of In Vivo–Expressed Antigens of<i>Staphylococcus aureus</i>and Their Use in Vaccinations for Protection against Nasal Carriage de réir Simon R. Clarke, Kirsten J. Brummell, Malcolm J. Horsburgh, Philip W. McDowell, Sharifah Aminah Syed Mohamad, Melanie R. Stapleton, Jorge Luis Arroyo-Acevedo, Robert C. Read, Nicholas P. J. Day, Sharon J. Peacock, James J. Mond, John F. Kokai–Kun, Simon J. Foster
Foilsithe / Cruthaithe 2006Artigo
Uirlisí cuardaigh:
Ábhair a bhaineann le hábhar
Biology
Microbiology
Genetics
Bacteria
Medicine
Staphylococcus aureus
Antibiotics
Gene
Lysostaphin
Virology
Biochemistry
Immunology
Pathology
Staphylococcal infections
Ceftriaxone
Internal medicine
Virulence
Alternative medicine
Antibody
Biofilm
Clostridium difficile
Clostridium perfringens
Enterotoxin
Escherichia coli
In vitro
Methicillin-resistant Staphylococcus aureus
Mupirocin
Mutant
Peptidoglycan
Pharmacokinetics